XML 17 R5.htm IDEA: XBRL DOCUMENT v3.25.3
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning balance (in shares) at Mar. 31, 2024   125,194,000      
Beginning balance at Mar. 31, 2024 $ 101,958 $ 125 $ 973,895 $ (11,553) $ (860,509)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock under stock plans (in shares)   2,769,000      
Issuance of common stock under stock plans 0 $ 3 (3)    
Stock-based compensation expense 13,279   13,279    
Unrealized investment loss (5)     (5)  
Foreign currency translation adjustment (354)     (354)  
Net income (loss) (10,290)       (10,290)
Ending balance (in shares) at Jun. 30, 2024   127,963,000      
Ending balance at Jun. 30, 2024 104,588 $ 128 987,171 (11,912) (870,799)
Beginning balance (in shares) at Mar. 31, 2024   125,194,000      
Beginning balance at Mar. 31, 2024 101,958 $ 125 973,895 (11,553) (860,509)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (24,833)        
Ending balance (in shares) at Sep. 30, 2024   130,517,000      
Ending balance at Sep. 30, 2024 109,812 $ 131 998,572 (3,549) (885,342)
Beginning balance (in shares) at Jun. 30, 2024   127,963,000      
Beginning balance at Jun. 30, 2024 104,588 $ 128 987,171 (11,912) (870,799)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock under stock plans (in shares)   1,479,000      
Issuance of common stock under stock plans 0 $ 2 (2)    
ESPP share issuance (in shares)   1,075,000      
ESPP share issuance 1,683 $ 1 1,682    
Stock-based compensation expense 9,721   9,721    
Foreign currency translation adjustment 8,363     8,363  
Net income (loss) (14,543)       (14,543)
Ending balance (in shares) at Sep. 30, 2024   130,517,000      
Ending balance at Sep. 30, 2024 $ 109,812 $ 131 998,572 (3,549) (885,342)
Beginning balance (in shares) at Mar. 31, 2025 134,355,000 134,355,000      
Beginning balance at Mar. 31, 2025 $ 122,204 $ 134 1,018,902 (9,111) (887,721)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock under stock plans (in shares)   2,692,000      
Issuance of common stock under stock plans 0 $ 3 (3)    
Common shares withheld for settlement of taxes in connection with equity-based compensation (in shares)   (300,000)      
Common shares withheld for settlement of taxes in connection with equity-based compensation (489)   (489)    
Repurchase of common stock (1,848) $ (1) (1,847)    
Repurchase of common stock (in shares)   (1,000,000)      
Stock-based compensation expense 6,380   6,380    
Foreign currency translation adjustment 6,258     6,258  
Net income (loss) (4,315)       (4,315)
Ending balance (in shares) at Jun. 30, 2025   135,747,000      
Ending balance at Jun. 30, 2025 $ 128,190 $ 136 1,022,943 (2,853) (892,036)
Beginning balance (in shares) at Mar. 31, 2025 134,355,000 134,355,000      
Beginning balance at Mar. 31, 2025 $ 122,204 $ 134 1,018,902 (9,111) (887,721)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) $ (3,548)        
Ending balance (in shares) at Sep. 30, 2025 138,569,000 138,569,000      
Ending balance at Sep. 30, 2025 $ 133,162 $ 139 1,028,971 (4,679) (891,269)
Beginning balance (in shares) at Jun. 30, 2025   135,747,000      
Beginning balance at Jun. 30, 2025 128,190 $ 136 1,022,943 (2,853) (892,036)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock under stock plans (in shares)   2,231,000      
Issuance of common stock under stock plans 0 $ 2 (2)    
ESPP share issuance (in shares)   817,000      
ESPP share issuance 1,228 $ 1 1,227    
Common shares withheld for settlement of taxes in connection with equity-based compensation (in shares)   (226,000)      
Common shares withheld for settlement of taxes in connection with equity-based compensation (479)   (479)    
Stock-based compensation expense 5,282   5,282    
Foreign currency translation adjustment (1,826)     (1,826)  
Net income (loss) $ 767       767
Ending balance (in shares) at Sep. 30, 2025 138,569,000 138,569,000      
Ending balance at Sep. 30, 2025 $ 133,162 $ 139 $ 1,028,971 $ (4,679) $ (891,269)